Allopregnanolone Regenerative Therapeutic for Mild Alzheimer's Disease
Public ClinicalTrials.gov record NCT04838301. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Safety and Efficacy of Allopregnanolone (Allo) as a Regenerative Therapeutic for Alzheimer's Disease: Multicenter, Double-Blind, Randomized, Placebo-Controlled, Phase 2 Clinical Trial
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
A phase 2, double-blind, randomized, placebo-controlled clinical trial to evaluate the safety and efficacy of Allopregnanolone as a regenerative therapeutic for Alzheimer's disease.
Study identification
- NCT ID
- NCT04838301
- Recruitment status
- Active, not recruiting
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 100 participants
Conditions and interventions
Eligibility (public fields only)
- Age range
- 55 Years to 80 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 14, 2023
- Primary completion
- Nov 17, 2026
- Completion
- Mar 17, 2027
- Last update posted
- Jun 29, 2026
2023 – 2027
United States locations
- U.S. sites
- 9
- U.S. states
- 4
- U.S. cities
- 8
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Perseverance Research Center | Scottsdale | Arizona | 85253 | — |
| University of Arizona / Clinical & Translational Sciences Research Center | Tucson | Arizona | 85721 | — |
| ATP Clinical Research | Costa Mesa | California | 92626 | — |
| Syrentis Clinical Research | Santa Ana | California | 92705 | — |
| Optimus U Corporation | Miami | Florida | 33135 | — |
| Miami Jewish Health | Miami | Florida | 33137 | — |
| Combined Research Orlando | Orlando | Florida | 32807 | — |
| Conquest Research | Winter Park | Florida | 32789 | — |
| MedVadis Research | Waltham | Massachusetts | 02451 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04838301, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 29, 2026 · Synced Sep 3, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT04838301 live on ClinicalTrials.gov.